Manufacturer record
Nestor Pharmaceuticals Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
31 batches manufactured by Nestor Pharmaceuticals Limited (Haryana) were declared Not of Standard Quality between January 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
31 records linked to Nestor Pharmaceuticals Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
31Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
31
NSQ batches since 2019
18
Products affected
Dissolution
Most common failure
Jul 2026
Latest alert
Flagged batches per year
2019 · 52021 · 12022 · 72023 · 42024 · 62025 · 42026 · 4
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Oral Rehydration Salts I.P | ODSC-1010Mfg 2025-11 · Exp 2027-10 | Sample does not conform to IP standards. It fails the test Assay as per IP and hence declared as Not of Standard QualityAssay | RDTL ErnakulamState lab | Jul 2026 |
| Acetyl Salicylic Acid Tablets IP 75 mg | PFTC-23Mfg 2025-05 · Exp 2027-04 | Dissolution and AssayAssay | SDTL, Andhra Pradesh, VijayawadaState lab | May 2026 |
| Prednisolone Tablets IP 10mg | PHTC-02Mfg 2025-01 · Exp 2026-12 | DissolutionDissolution | DTL, ThiruvananthapuramState lab | Mar 2026 |
| Cefixime Oral Suspension 100 mg/5ml Dry Syrup 30 ml | CADB-07Mfg 2024-09 · Exp 2026-08 | The Sample fails the test 'Description, water and Assay as per IPAssay | DTL ThiruvananthapuramState lab | Mar 2026 |
| IRON AND FOLIC ACID TABLETS IP (Iron 60mg and Folic acid 0.5mg) | IQTB-39Mfg 2024-01 · Exp 2025-12 | Uniformity of Content & Assay for Folic AcidAssay | SDT&RL, BhubaneswarState lab | Nov 2025 |
| Ondansetron Tablets IP 4 mg | ONTB-06Mfg 2024-09 · Exp 2026-08 | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Ciprofloxacin Tablets IP 250 mg | CITB-02Mfg 2024-07 · Exp 2026-06 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Apr 2025 |
| Cefixime Oral Suspension IP Dry Syrup 30 ml | CADB- 02Mfg 2024-06 · Exp 2026-05 | It fails the test Assay, water and descriptive part for oral liquids as per IP , as specified in the Laboratory ProtocolAssay | DTL ThiruvananthapuramState lab | Apr 2025 |
| Frusemide Injection IP 20 mg | FRIB-03Mfg 2024-01 · Exp 2025-12 | It fails the test ?Sterility? as per IPSterility | DTL ThiruvananthapuramState lab | Sep 2024 |
| Cloxacillin Sodium Capsules IP 250 mg | CLCA-04Mfg 2023-04 · Exp 2025-03 | The sample does not conform to IP Standards with respect to ?Descriptive part? of hard gelatin capsules and further tests cannot be performed due to reasons secified in the laboratory protocolOther | DTL ThiruvananthapuramState lab | Sep 2024 |
| Frusemide Injection IP 20 mg | FRIB-03Mfg 2024-01 · Exp 2025-12 | It fails the test ?Sterility? as per IPSterility | DTL ThiruvananthapuramState lab | Aug 2024 |
| Cefixime Oral Suspension IP (Dry Syrup) | CADA-02Mfg 2023-09 · Exp 2025-08 | It fails the test ?Assay? and ?water? as per IPAssay | DTL ThiruvananthapuramState lab | Aug 2024 |
| Cephalexin Oral Suspension IP 125/500 | CHDA-01Mfg 2023-04 · Exp 2024-09 | It fails the test ?Assay? and Descriptive part as per IPAssay | DTL ThiruvananthapuramState lab | Jul 2024 |
| Frusemide Injection IP 20 mg | FRIA-11Mfg 2023-11 · Exp 2025-10 | It fails the test ?Sterility? as per IPSterility | SDTL ThiruvananthapuramState lab | Apr 2024 |
| Aciclovir Tablets IP 400 mg | YCTZ-01Mfg 2022-06 · Exp 2024-05 | Assay of AciclovirAssay | RDTL ChandigarhCDSCO lab | Jun 2023 |
| Iron and Folic Acid Tablets I.P. | IQTZ-371Mfg 2022-12 · Exp 2024-11 | Description, Assay and Uniformity of Content of Folic AcidAssay | CDTL KolkataCDSCO lab | Mar 2023 |
| Trypsin- Chymotrypsin Tablets (CHYMORAL FORTE TABLETS) | 2JH3H019Mfg 2021-04 · Exp 2023-03 | Disintegration test (Acid Medium)Disintegration | RDTL ChandigarhState lab | Jan 2023 |
| Telmisartan Tablets IP 40 mg | TETY-01Mfg 2021-04 · Exp 2023-03 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2023 |
| Ondansetron Tablets IP 4 mg | ONTZ-07Mfg 2022-04 · Exp 2024-03 | AssayAssay | RDTL ChandigarhCDSCO lab | Nov 2022 |
| Telmisartan Tablets I.P. 40 mg | TETY-01Mfg 2021-04 · Exp 2023-03 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Telmisartan Tablets IP 40 mg | TETY-01Mfg 2021-04 · Exp 2023-03 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
| IRON AND FOLIC ACID TABLETS IP | IQTY-312Mfg 2021-11 · Exp 2023-10 | Uniformity of Content (FolicUniformity of weight/content | RDTL ChandigarhCDSCO lab | Jun 2022 |
| Telmisartan Tablets IP 40mg | TETY-01Mfg 2021-04 · Exp 2023-03 | DissolutionDissolution | RDTL GuwahatiState lab | May 2022 |
| Telmisartan Tablets IP 40mg | TETY-01Mfg 2021-04 · Exp 2023-03 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2022 |
| Telmisartan Tablets IP 40 mg | TETY-01Mfg 2021-04 · Exp 2023-03 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2022 |
| Telmisartan Tablets IP 40 mg | TETY-01Mfg 2021-04 · Exp 2023-03 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2021 |
| Ciprofloxacin Tablets IP 250 mg | (10)CITW-31Mfg 2019-04 · Exp 2021-03 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Nov 2019 |
| Primaquine Tablets IP 2.5mg | PJVT-01Mfg 2018-02 · Exp 2020-01 | Uniformity of Content, Dissolution and AssayAssay | CDL KolkataCDSCO lab | Sep 2019 |
| Ciprofloxcin Tablets I.P. 500mg | RCTW-06Mfg 2019-01 · Exp 2021-12 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2019 |
| Calcium and Vitamin D3 Tablets IP (500 mg + 250 IU) | CWTV-56Mfg 2018-09 · Exp 2020-08 | Assay of Vitamin D3Assay | CDTL MumbaiCDSCO lab | Jul 2019 |
| PARACETAMOL TABLETS I.P. 500 MG | PTTV-38Mfg 2018-01 · Exp 2020-12 | Dissolution (Paracetamol)Dissolution | RDTL ChandigarhCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.